As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

The rising use of GLP-1 agonists to help manage the obesity epidemic is not only reshaping how consumers taking the ...

Eli Lilly is suing four telehealth companies that prescribe compounded versions of the pharmaceutical company's weight loss medications. Lilly filed four lawsuits on Wednesday claiming telehealth ...

The sudden and overwhelming demand for GLP-1 agonists, like Ozempic and Wegovy ... with far less stringent oversight than their name brand inspiration. Meanwhile, as influencers on social media ...

Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock ...

A class of drugs used to treat type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1RAs), have become a popular tool to help with weight loss. Explore common topics related to GLP-1RAs: ...

Increased awareness and knowledge of GLP-1/GIP receptor agonists among women, with insights into public perspectives on ...